Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

PD 0332991 (Palbociclib) HCl

Catalog No.
A8316
CDK4/6 inhibitor
Grouped product items
SizePriceStock Qty
Evaluation Sample
$30.00
In stock
5mg
$55.00
In stock
25mg
$90.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

PD 0332991 (Palbociclib) HCl (CAS 827022-32-2) is a selective, orally bioavailable inhibitor targeting cyclin-dependent kinases 4 and 6 (CDK4/6). By inhibiting CDK4/6, PD 0332991 prevents phosphorylation of retinoblastoma (Rb) protein, thereby inducing cell cycle arrest at the G1 phase. It exhibits inhibitory activity against CDK4 and CDK6 with IC50 values of 11 nM and 16 nM, respectively. PD 0332991 demonstrates antiproliferative activity in Rb-positive tumor cells, suppressing tumor growth and promoting G1 arrest in models of multiple myeloma and ER-positive/HER2-amplified breast cancer cell lines.

References:
[1] Ivan Diaz-Padilla, Lillian L. Siu and Ignacio Duran. Cyclin-dependent kinase inhibitors as potential targeted anticancer agents. Invest New Drugs. 2009, 27: 586–594.
[2] Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los and Dennis J Slamon. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Research. 2009, 11: R77.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt483.99
Cas No.827022-32-2
FormulaC24H30ClN7O2
SynonymsPD0332991; PD-0332991; PD 0332991
Solubility≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic
Chemical Name6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride
SDFDownload SDF
Canonical SMILESO=C1N(C2=NC(NC3=NC=C(C=C3)N4CCNCC4)=NC=C2C(C)=C1C(C)=O)C5CCCC5.Cl
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment: [1]

Cell lines

MDA-MB-453 cells

Preparation method

The solubility of this compound in DMSO is

Reaction Conditions

80 nM, 24 hours

Applications

MDA-MB-453 breast carcinoma cells exposed to varying concentrations of PD 0332991 for 24 hours showed a significant increase in the percentage of cells in G1 in the presence of as little as 0.04 μmol/L PD 0332991 with a concomitant decline in other phases of the cell cycle. Maximum effects were attained at 0.08 μmol/L and an exclusive G1 arrest was maintained even at concentrations as high as 10 μmol/L, consistent with the complete absence of any other effects on the cell cycle.

Animal experiment: [1]

Animal models

Mice bearing Colo-205 colon carcinoma xenografts

Dosage form

Oral administration, 150 or 75 mg/kg, daily for 14 days

Applications

Administration of PD 0332991 produced rapid tumor regressions and a corresponding tumor growth delay of about 50 days with >1 log of tumor cell kill at the highest dose tested. At 37.5 mg/kg, the tumor slowly regressed during treatment. Even at doses as low as 12.5 mg/kg, a 13 day growth delay was obtained indicating a 90% inhibition of tumor growth rate.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1] Fry D W, Harvey P J, Keller P R, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Molecular cancer therapeutics, 2004, 3(11): 1427-1438.

Biological Activity

Description Palbociclib (PD-0332991) HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM.
Targets CDK4/cyclin D1 CDK6/cyclin D2        
IC50 11 nM 16 nM        

Quality Control